Teresa Helsten Selected Research

ErbB Receptors (EGF Receptor)

1/2020

MK-2206 and Standard Neoadjuvant Chemotherapy Improves Response in Patients With Human Epidermal Growth Factor Receptor 2-Positive and/or Hormone Receptor-Negative Breast Cancers in the I-SPY 2 Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Teresa Helsten Research Topics

Disease

12	Breast Neoplasms (Breast Cancer) 03/2024 - 05/2011
11	Neoplasms (Cancer) 01/2024 - 09/2014
3	Pathologic Complete Response 11/2021 - 01/2020
2	Residual Neoplasm 11/2021 - 07/2016
1	Bone Diseases (Bone Disease) 01/2021
1	Disease Progression 01/2021
1	Triple Negative Breast Neoplasms 01/2020
1	Retinoblastoma (Glioblastoma, Retinal) 01/2016
1	Neoplasm Metastasis (Metastasis) 09/2014
1	Acquired Immunodeficiency Syndrome (AIDS) 05/2011

Drug/Important Bio-Agent (IBA)

4	Paclitaxel (Taxol)FDA LinkGeneric 03/2024 - 01/2021
4	Hormones (Hormone)IBA 01/2021 - 07/2016
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2021 - 05/2011
2	Trastuzumab (Herceptin)FDA Link 11/2021 - 07/2016
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2021 - 01/2016
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2020
1	AntigensIBA 01/2024
1	Monoclonal AntibodiesIBA 01/2024
1	taxaneIBA 01/2024
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2021
1	pertuzumabIBA 11/2021
1	Ado-Trastuzumab EmtansineIBA 11/2021
1	veliparibIBA 01/2021
1	exemestane (Aromasin)FDA Link 01/2021
1	abemaciclibIBA 01/2021
1	Fulvestrant (Faslodex)FDA Link 01/2021
1	Letrozole (Femara)FDA LinkGeneric 01/2021
1	Anastrozole (Arimidex)FDA LinkGeneric 01/2021
1	PlatinumIBA 01/2021
1	Tamoxifen FDA LinkGeneric 01/2021
1	Carboplatin (JM8)FDA LinkGeneric 01/2021
1	Aromatase InhibitorsIBA 01/2021
1	MK 2206IBA 01/2020
1	ErbB Receptors (EGF Receptor)IBA 01/2020
1	TOR Serine-Threonine KinasesIBA 01/2020
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2020
1	pembrolizumabIBA 01/2020
1	Circulating Tumor DNAIBA 01/2019
1	neratinibIBA 07/2016
1	regorafenibIBA 09/2015
1	ponatinibIBA 09/2015
1	LigandsIBA 09/2015
1	lenvatinibIBA 09/2015
1	pazopanib FDA Link 09/2015
1	Methotrexate (Mexate)FDA LinkGeneric 09/2014
1	Cytarabine (Cytosar-U)FDA LinkGeneric 09/2014
1	Zolpidem (Ambien)FDA LinkGeneric 05/2011
1	Lorazepam (Ativan)FDA LinkGeneric 05/2011

Therapy/Procedure

9	Therapeutics 01/2024 - 11/2015
6	Neoadjuvant Therapy 11/2021 - 05/2011
5	Drug Therapy (Chemotherapy) 11/2021 - 05/2011
2	Adjuvant Chemotherapy 01/2020 - 05/2011
1	Investigational Therapies (Experimental Therapy) 11/2021